Immunology

Your reaction matters: The role of antibodies in COVID-19 response

Efforts to contain the COVID-19 pandemic have largely focused on vaccine development and deployment. But how exactly do our immune systems respond to COVID-19 vaccines? The major response occurs in one of two ways: the production ...

Vaccination

Researchers on the cusp of a new vaccine modality breakthrough

Professor Bernd Rehm and Dr. Shuxiong Chen from the Griffith Institute for Drug Discovery (GRIDD) and Griffith's Center for Cell Factories and Biopolymers have succeeded in developing a new vaccine modality that is a stable ...

Vaccination

Guiding vaccine development with machine learning

From tackling homework challenges to drafting emails, people are discovering a vast array of applications for natural language processing tools like generative artificial intelligence (AI) engines.

Diseases, Conditions, Syndromes

mRNA has entered the lexicon

Catastrophe occasionally apologizes for itself by coughing up a consolation prize. World War II gave us penicillin. So let's count our blessings.

Immunology

Low binding affinity shown to improve vaccine efficacy

Conventional vaccines usually contain antigens—components of the respective pathogens—that bind to receptors on the surface of their target cells in order to trigger the disease. Scientists at the Berlin Institute of ...

Medical research

The potential and challenges of mucosal COVID-19 vaccines

In November 2022, the National Institute of Allergy and Infectious Diseases (NIAID) co-hosted a virtual workshop on the importance and challenges of developing mucosal vaccines for SARS-COV-2. The highlights of this workshop ...

page 10 from 35